Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis

Published:2019-08 Issue:9 Volume:17 Page:1860-1866.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Stokkeland Knut,Höijer Jonas,Bottai Matteo,Söderberg-Löfdal Karin,Bergquist Annika^ORCID

Funder

Swedish Society of Medicine

Swedish Cancer Society and Stockholm County Council

Department of Medicine

Karolinska Institutet

Ruth and Richard Julins Foundation

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Primary sclerosing cholangitis;Lazaridis;N Engl J Med,2016

2. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis;Boonstra;Hepatology,2013

3. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis;Bergquist;J Hepatol,2002

4. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis;Triantos;Aliment Pharmacol Ther,2011

5. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis;Lindstrom;Clin Gastroenterol Hepatol,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically predicted gut microbiota mediate the association between plasma lipidomics and primary sclerosing cholangitis;BMC Gastroenterology;2024-05-08

2. New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: a drug Mendelian randomization study;2024-04-25

3. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape;Expert Opinion on Investigational Drugs;2024-03-18

4. Impact of statins in the liver: A bane or a boon?;Canadian Liver Journal;2024-03-13

5. Treatment of Primary Sclerosing Cholangitis Including Transplantation;Clinics in Liver Disease;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3